No Data
Express News | Shares in Alaunos Therapeutics Inc Hit Session Low With Volume Spike, Last Down 7.8% at $2
Precigen Terminates License Agreement With Alaunos Therapeutics
Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy
Express News | Alaunos Therapeutics : Co Provided Written Notice to Precigen to Terminate a&R License Agreement
Alaunos Therapeutics | 10-Q: Q2 2024 Earnings Report
Why Domino's Pizza Shares Are Trading Lower By Over 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
No Data
No Data